Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin

NCT00693771 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
313
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi